Table 2 The difference in the incidence of ≥ grade 2 RP at different subgroups
Factors | Subgroup | No. Of grade <2RP(N)(%) | No. Of grade ≥ 2RP(N)(%) | P Value |
|---|---|---|---|---|
CCRT | V20Gy< 25% | 27(81.8) | 6(18.2) | Â |
V20Gy ≥ 25% | 30(69.8) | 13(30.2) | 0.229 | |
V20Gy ≥ 25% without Amifostine V20Gy ≥ 25% with Amifostine | 10(50.0) | 10(50.0) |  | |
20(87.0) | 3(13.0) | 0.008* | ||
CCRT + Endostar | V20Gy < 25% | 29(100.0) | 0(0.0) | Â |
V20Gy ≥ 25% | 11(64.7) | 6(35.3) | 0.001* | |
V20Gy < 25% | No Endostar | 27(81.8) | 6(18.2) | Â |
Endostar | 29(100.0) | 0(0.0) | 0.026* | |
V20Gy ≥ 25% | Amifostine + No Endostar | 20(87.0) | 3(13.0) |  |
Amifostine + Endostar | 9(90.0) | 1(10.0) | >0.05 |